Developer docs
API playgroundTry for free, no card

Search company profiles

Ambee

Full company profile

uuid003hbd7

Namestring
Ambee
Legal namestring
Ambee Pharmaceuticals PLC
Websiteurl
ambeepharma.com
Company typeenum
Public
Founded yearint
1976
Descriptiontext

Ambee Pharmaceuticals PLC is a Bangladeshi generic pharmaceutical manufacturer founded on February 4, 1976, and listed on the Dhaka Stock Exchange (ticker: AMBEE) and the Chittagong Stock Exchange. The company manufactures tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories — including antibiotics (HIFLOX, LEXLO, MYZID, DOXILIN), NSAIDs (AROLAK, HITFLAM, NAPROXIN), PPIs (X-Pro, OM), antihistamines (ACTIZEN, AMBFEX), cardiovascular agents (LOTAS, VEROSPIRON), vitamins and minerals (VITEX GOLD, ZINC-S, AMBEECAL), psychotropics (NOCTIN, REM, SEDUXEN, SERA), and anthelmintics (TRIBEN) — under WHO cGMP and ISO 9001:2015 certified manufacturing at its facility in Tejgaon Industrial Area, Dhaka.

The company's core technology stack is conventional small-molecule generic manufacturing governed by U.S. Drug Authority CGMP standards, with quality systems certified by United Registrar of Systems Ltd. (URS) of the UK. Its principal intangible asset is a joint venture with Medimpex of Budapest, Hungary, dating to 1976, which provides formulation expertise and has scaled to 76 jointly developed products. Ambee monetizes through one-time product sales distributed via a wholly-owned in-house network: a National Distribution Cell in Dhaka and eight regional sales depots across Khulna, Chittagong, Bogra, Sylhet, Barisal, Comilla, Mymensingh, Rangpur, and Rajshahi, supported by ~200 field sales personnel and 150+ distribution staff.

The primary customer base is healthcare consumers across Bangladesh served through chemists and pharmacies, with a secondary push into government and NGO supply contracts in Asia and Africa. International revenue comes from exports to Afghanistan, Myanmar, Cambodia, and Bhutan via distribution partners. Ownership is concentrated in the founding Aziz Mohammad Bhai family; management is led by Chairman Aziz Mohammad Bhai and Managing Director Kazi Tanzzina Ferdous, with a CFO (A.K.M. Khairul Aziz) who has been with the company for 38 years and two recently appointed independent directors (2020, 2021). No revenue, profitability, or fundraising figures are publicly disclosed.

Short descriptiontext

Ambee Pharmaceuticals PLC, founded in 1976 and listed on the Dhaka and Chittagong Stock Exchanges, manufactures generic pharmaceutical products under WHO cGMP and ISO 9001:2015 certification at its Dhaka facility and distributes them across Bangladesh and to Afghanistan, Myanmar, Cambodia, and Bhutan.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDhaka, Bangladesh
HQ citystring
Dhaka
HQ countrystring
Bangladesh
HQ regionstring
Asia
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical manufacturing, pharmaceutical formulations production, WHO cGMP manufacturing, pharmaceutical distribution services, tablet capsule injectable production
Industry2 codes
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Product Sales
TypeOne Time License
Description

Ambee Pharmaceuticals generates revenue through the manufacture and sale of pharmaceutical products including tablets, capsules, liquids, gels, and injectables. The company sells through its own distribution network across Bangladesh and exports to neighboring countries.

2Joint Venture Products
TypeOne Time License
Description

Revenue from 76 products developed through joint venture with Medimpex Hungary, including antibiotics, anti-ulcerants, psychotropics, antacids, gels, vitamins, and injectables.

ambeepharma.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Ambee Pharmaceuticals PLC manufactures and sells over 120 generic pharmaceutical formulations including tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories. Products are manufactured at WHO cGMP compliant facilities in Dhaka, Bangladesh, with 76 formulations developed through a joint venture with Medimpex Hungary. The company distributes products nationwide in Bangladesh through its own sales depots and field force, and exports to Afghanistan, Myanmar, Cambodia, and Bhutan via international distribution partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Established in 1976, with first year sales over 1 Crore BDT
+1 more record
Product overview1 text field

Ambee Pharmaceuticals PLC is a pharmaceutical manufacturing and distribution company established in 1976 in Bangladesh. The company produces a portfolio of over 76 pharmaceutical products across multiple therapeutic categories including tablets, capsules, liquids, gels, and injectables. The product portfolio includes NO-SPA (Drotaverine Hydrochloride), ACT PLUS (Paracetamol & Caffeine), ZINC-S SYRUP, VITEX GOLD (Multivitamin with Minerals A-Z), AROLAK (Ketorolac Tromethamine), X-Pro 20/40 (Esomeprazole Magnesium Trihydrate), along with antibiotics such as HIFLOX, LEXLO, MYZID, DOXILIN, antihistamines including ACTIZEN and AMBFEX, cardiovascular products like LOTAS and VEROSPIRON, and various other therapeutic medications. The company operates as a WHO cGMP certified manufacturer with ISO 9001:2015 quality management certification and distributes products domestically through a network of sales depots and internationally to markets in Afghanistan, Myanmar, Cambodia, Bhutan, and is expanding to Africa and SAARC regions.

Product and service39 records
1NO-SPA
CategoryAntispasmodic Pharmaceuticals
Description

Drotaverine Hydrochloride antispasmodic available as tablets and injection, used for smooth muscle spasm relief.

2ZINC-S SYRUP
CategoryMineral and Vitamin Supplements
Description

Zinc Sulphate Monohydrate oral syrup for mineral supplementation.

3ACT PLUS
CategoryAnalgesic Pharmaceuticals
Description

Paracetamol and Caffeine combination tablet for antipyretic and analgesic use.

4AROLAK
CategoryNSAID Pharmaceuticals
Description

Ketorolac Tromethamine NSAID available as tablets and injection for pain and inflammation management.

5X-Pro (Esomeprazole 20mg and 40mg)
CategoryGastrointestinal Pharmaceuticals
Description

Esomeprazole Magnesium Trihydrate capsules in 20mg and 40mg strengths for proton pump inhibition / acid reflux treatment.

6VITEX GOLD
CategoryMultivitamin Supplements
Description

Multivitamin with Minerals A-Z combined preparation tablets available in 15s and 30s pack sizes for nutritional supplementation.

7VITEX-M TABLET
CategoryVitamin and Mineral Supplements
Description

Multi Vitamin with Minerals tablet supplement.

8TRIBEN (Albendazole)
CategoryAnthelmintic Pharmaceuticals
Description

Albendazole anthelmintic available as oral suspension and 400mg tablets for parasitic worm infection treatment.

9AMETROL-VT TABLET
CategoryAntibacterial and Antifungal Pharmaceuticals
Description

Metronidazole and Miconazole Nitrate combination tablet for combined antibacterial and antifungal treatment.

10DIPHEDAN TABLET
CategoryAnticonvulsant Pharmaceuticals
Description

Phenytoin 100mg anticonvulsant tablet for seizure management.

11AFLUZOLE (Fluconazole 50mg and 150mg)
CategoryAntifungal Pharmaceuticals
Description

Fluconazole antifungal capsules available in 50mg and 150mg strengths for systemic and topical fungal infection treatment.

12ACTIZEN (Cetirizine)
CategoryAntihistamine Pharmaceuticals
Description

Cetirizine Dihydrochloride antihistamine available as oral syrup and 10mg tablets for allergic rhinitis and urticaria.

13AMBFEX (Fexofenadine 120mg and 180mg)
CategoryAntihistamine Pharmaceuticals
Description

Fexofenadine antihistamine tablets in 120mg and 180mg strengths for allergic condition management.

14LOTAS TABLET
CategoryAntihypertensive Pharmaceuticals
Description

Losartan Potassium 50mg antihypertensive tablet for blood pressure management.

15KLION (Metronidazole)
CategoryAntiprotozoal Pharmaceuticals
Description

Metronidazole antiprotozoal available as Benzoyl Metronidazole oral suspension and 400mg tablets for protozoal and anaerobic infections.

16ACT (Paracetamol)
CategoryAnalgesic Pharmaceuticals
Description

Paracetamol antipyretic and analgesic available as 120mg/5ml oral suspension and 500mg tablets for fever and pain relief.

17ALUCTIN CAPSULE
CategoryBenzodiazepine Pharmaceuticals
Description

Flurazepam 30mg benzodiazepine capsule for sedative and hypnotic treatment.

18NOCTIN TABLET
CategoryBenzodiazepine Pharmaceuticals
Description

Nitrazepam 5mg benzodiazepine tablet for sedative and hypnotic treatment.

19REM TABLET
CategoryBenzodiazepine Pharmaceuticals
Description

Bromazepam 3mg benzodiazepine tablet for sedative and anxiolytic treatment.

20SEDUXEN (Diazepam)
CategoryBenzodiazepine Pharmaceuticals
Description

Diazepam benzodiazepine available as 10mg injection and 5mg tablets for sedative, anxiolytic, and muscle relaxant treatment.

21AMASON TABLET
CategoryCorticosteroid Pharmaceuticals
Description

Dexamethasone 0.5mg corticosteroid tablet for anti-inflammatory and immunosuppressive treatment.

22VEROSPIRON (Spironolactone)
CategoryDiuretic Pharmaceuticals
Description

Spironolactone diuretic available as 25mg standalone tablet and as Spironolactone plus Frusemide combination tablet (VEROSPIRON PLUS) for edema and cardiovascular indications.

23HIFLOX (Ciprofloxacin 500mg and 750mg)
CategoryFluoroquinolone Antibiotics
Description

Ciprofloxacin fluoroquinolone antibiotic tablets in 500mg and 750mg strengths for bacterial infection treatment.

24LEXLO (Levofloxacin 250mg and 500mg)
CategoryFluoroquinolone Antibiotics
Description

Levofloxacin Hemihydrate fluoroquinolone antibiotic tablets in 250mg and 500mg strengths for respiratory and urinary tract bacterial infections.

25PREDNISOLONE TABLET
CategoryGlucocorticoid Pharmaceuticals
Description

Prednisolone 5mg glucocorticoid tablet for anti-inflammatory and immunosuppressive therapy.

26FERRITIN-TR CAPSULE
CategoryHematinic Supplements
Description

Ferrous Sulphate and Folic Acid combination capsule for iron deficiency anemia treatment and supplementation.

27AMBKUST
CategoryRespiratory Pharmaceuticals
Description

Montelukast 10mg leukotriene receptor antagonist tablet for asthma and allergic airway disease management.

28MYZID 500 TABLET
CategoryMacrolide Antibiotics
Description

Azithromycin Dihydrate 500mg macrolide antibiotic tablet for bacterial infection treatment.

29MYCIN SUSPENSION
CategoryMacrolide Antibiotics
Description

Erythromycin Ethyl Succinate macrolide antibiotic oral suspension for bacterial infection treatment.

30HITFLAM (Diclofenac)
CategoryNSAID Pharmaceuticals
Description

Diclofenac Sodium NSAID available as 10gm topical gel, 75mg injection, and 100mg sustained-release tablet for pain and inflammation relief.

31NAPROXIN TABLET
CategoryNSAID Pharmaceuticals
Description

Naproxen 500mg NSAID tablet for pain, inflammation, and fever management.

32ADOREX (Domperidone)
CategoryGastrointestinal Pharmaceuticals
Description

Domperidone prokinetic available as 5mg/ml pediatric drops, 5mg/5ml oral suspension, and 10mg tablets for gastrointestinal motility disorders.

33OM (Omeprazole 20mg and 40mg)
CategoryGastrointestinal Pharmaceuticals
Description

Omeprazole BP proton pump inhibitor capsules in 20mg (100s pack) and 40mg (30s pack) strengths for gastric acid-related disorders.

34VITEX INJECTION
CategoryVitamin Supplements
Description

Vitamin B-Complex injection for parenteral vitamin supplementation.

35SERA TABLET
CategoryAntidepressant Pharmaceuticals
Description

Sertraline HCL 50mg SSRI tablet for depression and related psychiatric conditions.

36NOSTIS TABLET
CategoryJoint Health Supplements
Description

Glucosamine Sulphate and Chondroitin Sulphate tablet for cartilage formation support in joint health.

37DOXILIN CAPSULE
CategoryTetracycline Antibiotics
Description

Doxycycline 100mg tetracycline antibiotic capsule for bacterial infection treatment.

38FOLAC TABLET
CategoryVitamin Supplements
Description

Folic Acid 5mg tablet for vitamin supplementation and prenatal care.

39AMBEECAL (Calcium Carbonate)
CategoryCalcium Supplements
Description

Calcium Carbonate 500mg tablet (AMBEECAL) and Calcium Carbonate plus Vitamin D3 tablet (AMBEECAL-D) for calcium supplementation and bone health.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1976-01-01
Description

Ambee entered into a joint venture with Medimpex of Budapest, Hungary (a famous multinational company). The venture began operations with a modest portfolio of 17 jointly developed products and is now operating at full scale with an expanded range of 76 products. This partnership brings global pharmaceutical expertise to Bangladesh manufacturing operations.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Renata PLC
TypeDirect peer
Description

Leading Bangladeshi pharma manufacturer (formerly Pfizer Bangladesh) producing generics, animal health, and specialty products. Direct competitor with broader therapeutic coverage than Ambee.

TypeDirect peer
Description

Bangladesh-based generic pharmaceutical manufacturer with a broad portfolio of tablets, capsules, liquids, and injectables. Direct competitor in the domestic Bangladesh generics market.

TypeDirect peer
Description

Bangladeshi generic pharmaceutical manufacturer producing tablets, capsules, liquids, and injectables. Closely comparable to Ambee in product categories and Bangladesh market focus.

TypeDirect peer
Description

Largest pharmaceutical manufacturer in Bangladesh, producing generics across tablets, capsules, liquids, and injectables. Direct competitor to Ambee in domestic Bangladesh generics, also exporting regionally.

TypeDirect peer
Description

Diversified Bangladeshi conglomerate with a significant pharmaceutical division manufacturing generics across multiple therapeutic areas. Competes directly with Ambee in domestic Bangladesh market.

TypeDirect peer
Description

Bangladesh-based pharmaceutical manufacturer with broad generic portfolio and own nationwide distribution. Comparable mid-sized competitor to Ambee in domestic market.

TypeDirect peer
Description

Bangladesh-based pharmaceutical manufacturer producing generics in tablets, capsules, liquids, injectables and creams. Directly comparable to Ambee in size, product mix, and distribution model.

TypeDirect peer
Description

One of the top Bangladeshi pharmaceutical companies producing a wide range of generics including tablets, capsules, injectables, and biologics. Comparable in product breadth and domestic distribution model to Ambee.

9Beximco Pharmaceuticals
TypeDirect peer
Description

Major Bangladeshi generic pharma manufacturer with broad therapeutic portfolio and export operations. Competes directly with Ambee across multiple therapeutic categories in Bangladesh and export markets.

10Globe Pharmaceuticals
TypeDirect peer
Description

Bangladeshi generic pharma manufacturer producing a wide range of therapeutic categories. Closely comparable to Ambee in scale, product portfolio, and Bangladesh domestic market focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ambee

Generic Pharmaceutical Manufacturingambeepharma.com

Ambee Pharmaceuticals PLC, founded in 1976 and listed on the Dhaka and Chittagong Stock Exchanges, manufactures generic pharmaceutical products under WHO cGMP and ISO 9001:2015 certification at its Dhaka facility and distributes them across Bangladesh and to Afghanistan, Myanmar, Cambodia, and Bhutan.

What Ambee does

Ambee Pharmaceuticals PLC is a Bangladeshi generic pharmaceutical manufacturer founded on February 4, 1976, and listed on the Dhaka Stock Exchange (ticker: AMBEE) and the Chittagong Stock Exchange. The company manufactures tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories — including antibiotics (HIFLOX, LEXLO, MYZID, DOXILIN), NSAIDs (AROLAK, HITFLAM, NAPROXIN), PPIs (X-Pro, OM), antihistamines (ACTIZEN, AMBFEX), cardiovascular agents (LOTAS, VEROSPIRON), vitamins and minerals (VITEX GOLD, ZINC-S, AMBEECAL), psychotropics (NOCTIN, REM, SEDUXEN, SERA), and anthelmintics (TRIBEN) — under WHO cGMP and ISO 9001:2015 certified manufacturing at its facility in Tejgaon Industrial Area, Dhaka.

The company's core technology stack is conventional small-molecule generic manufacturing governed by U.S. Drug Authority CGMP standards, with quality systems certified by United Registrar of Systems Ltd. (URS) of the UK. Its principal intangible asset is a joint venture with Medimpex of Budapest, Hungary, dating to 1976, which provides formulation expertise and has scaled to 76 jointly developed products. Ambee monetizes through one-time product sales distributed via a wholly-owned in-house network: a National Distribution Cell in Dhaka and eight regional sales depots across Khulna, Chittagong, Bogra, Sylhet, Barisal, Comilla, Mymensingh, Rangpur, and Rajshahi, supported by ~200 field sales personnel and 150+ distribution staff.

The primary customer base is healthcare consumers across Bangladesh served through chemists and pharmacies, with a secondary push into government and NGO supply contracts in Asia and Africa. International revenue comes from exports to Afghanistan, Myanmar, Cambodia, and Bhutan via distribution partners. Ownership is concentrated in the founding Aziz Mohammad Bhai family; management is led by Chairman Aziz Mohammad Bhai and Managing Director Kazi Tanzzina Ferdous, with a CFO (A.K.M. Khairul Aziz) who has been with the company for 38 years and two recently appointed independent directors (2020, 2021). No revenue, profitability, or fundraising figures are publicly disclosed.

Ambee firmographics

Firmographics
Name
Ambee
Legal name
Ambee Pharmaceuticals PLC
Website
https://ambeepharma.com
Company type
Public
Founded year
1976
Operating status
Operating
Headcount range
51–100 employees
Short description
Ambee Pharmaceuticals PLC, founded in 1976 and listed on the Dhaka and Chittagong Stock Exchanges, manufactures generic pharmaceutical products under WHO cGMP and ISO 9001:2015 certification at its Dhaka facility and distributes them across Bangladesh and to Afghanistan, Myanmar, Cambodia, and Bhutan.
Ownership category
akta.pro rank

Ambee industry classification

Industry
Product category
Generic Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Generic pharmaceutical manufacturing
  • Pharmaceutical formulations production
  • WHO cGMP manufacturing
  • Pharmaceutical distribution services
  • Tablet capsule injectable production

Where Ambee is headquartered

Location

Headquarters

HQ city
Dhaka
HQ country
Bangladesh
HQ region
Asia

Offices11 records

Markets served

Ambee business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

  1. Pharmaceutical Product Sales: Ambee Pharmaceuticals generates revenue through the manufacture and sale of pharmaceutical products including tablets, capsules, liquids, gels, and injectables. The company sells through its own distribution network across Bangladesh and exports to neighboring countries.
  2. Joint Venture Products: Revenue from 76 products developed through joint venture with Medimpex Hungary, including antibiotics, anti-ulcerants, psychotropics, antacids, gels, vitamins, and injectables.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Ambee product offering

Product offering

Core offering

Ambee Pharmaceuticals PLC manufactures and sells over 120 generic pharmaceutical formulations including tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories. Products are manufactured at WHO cGMP compliant facilities in Dhaka, Bangladesh, with 76 formulations developed through a joint venture with Medimpex Hungary. The company distributes products nationwide in Bangladesh through its own sales depots and field force, and exports to Afghanistan, Myanmar, Cambodia, and Bhutan via international distribution partners.

Product overview

Ambee Pharmaceuticals PLC is a pharmaceutical manufacturing and distribution company established in 1976 in Bangladesh. The company produces a portfolio of over 76 pharmaceutical products across multiple therapeutic categories including tablets, capsules, liquids, gels, and injectables. The product portfolio includes NO-SPA (Drotaverine Hydrochloride), ACT PLUS (Paracetamol & Caffeine), ZINC-S SYRUP, VITEX GOLD (Multivitamin with Minerals A-Z), AROLAK (Ketorolac Tromethamine), X-Pro 20/40 (Esomeprazole Magnesium Trihydrate), along with antibiotics such as HIFLOX, LEXLO, MYZID, DOXILIN, antihistamines including ACTIZEN and AMBFEX, cardiovascular products like LOTAS and VEROSPIRON, and various other therapeutic medications. The company operates as a WHO cGMP certified manufacturer with ISO 9001:2015 quality management certification and distributes products domestically through a network of sales depots and internationally to markets in Afghanistan, Myanmar, Cambodia, Bhutan, and is expanding to Africa and SAARC regions.

Differentiator

Problem solved

Functional benefit

Products and services

  • NO-SPA Drotaverine Hydrochloride antispasmodic available as tablets and injection, used for smooth muscle spasm relief.
  • ZINC-S SYRUP Zinc Sulphate Monohydrate oral syrup for mineral supplementation.
  • ACT PLUS Paracetamol and Caffeine combination tablet for antipyretic and analgesic use.
  • AROLAK Ketorolac Tromethamine NSAID available as tablets and injection for pain and inflammation management.
  • X-Pro (Esomeprazole 20mg and 40mg) Esomeprazole Magnesium Trihydrate capsules in 20mg and 40mg strengths for proton pump inhibition / acid reflux treatment.
  • VITEX GOLD Multivitamin with Minerals A-Z combined preparation tablets available in 15s and 30s pack sizes for nutritional supplementation.
  • VITEX-M TABLET Multi Vitamin with Minerals tablet supplement.
  • TRIBEN (Albendazole) Albendazole anthelmintic available as oral suspension and 400mg tablets for parasitic worm infection treatment.
  • AMETROL-VT TABLET Metronidazole and Miconazole Nitrate combination tablet for combined antibacterial and antifungal treatment.
  • DIPHEDAN TABLET Phenytoin 100mg anticonvulsant tablet for seizure management.
  • AFLUZOLE (Fluconazole 50mg and 150mg) Fluconazole antifungal capsules available in 50mg and 150mg strengths for systemic and topical fungal infection treatment.
  • ACTIZEN (Cetirizine) Cetirizine Dihydrochloride antihistamine available as oral syrup and 10mg tablets for allergic rhinitis and urticaria.
  • AMBFEX (Fexofenadine 120mg and 180mg) Fexofenadine antihistamine tablets in 120mg and 180mg strengths for allergic condition management.
  • LOTAS TABLET Losartan Potassium 50mg antihypertensive tablet for blood pressure management.
  • KLION (Metronidazole) Metronidazole antiprotozoal available as Benzoyl Metronidazole oral suspension and 400mg tablets for protozoal and anaerobic infections.
  • ACT (Paracetamol) Paracetamol antipyretic and analgesic available as 120mg/5ml oral suspension and 500mg tablets for fever and pain relief.
  • ALUCTIN CAPSULE Flurazepam 30mg benzodiazepine capsule for sedative and hypnotic treatment.
  • NOCTIN TABLET Nitrazepam 5mg benzodiazepine tablet for sedative and hypnotic treatment.
  • REM TABLET Bromazepam 3mg benzodiazepine tablet for sedative and anxiolytic treatment.
  • SEDUXEN (Diazepam) Diazepam benzodiazepine available as 10mg injection and 5mg tablets for sedative, anxiolytic, and muscle relaxant treatment.
  • AMASON TABLET Dexamethasone 0.5mg corticosteroid tablet for anti-inflammatory and immunosuppressive treatment.
  • VEROSPIRON (Spironolactone) Spironolactone diuretic available as 25mg standalone tablet and as Spironolactone plus Frusemide combination tablet (VEROSPIRON PLUS) for edema and cardiovascular indications.
  • HIFLOX (Ciprofloxacin 500mg and 750mg) Ciprofloxacin fluoroquinolone antibiotic tablets in 500mg and 750mg strengths for bacterial infection treatment.
  • LEXLO (Levofloxacin 250mg and 500mg) Levofloxacin Hemihydrate fluoroquinolone antibiotic tablets in 250mg and 500mg strengths for respiratory and urinary tract bacterial infections.
  • PREDNISOLONE TABLET Prednisolone 5mg glucocorticoid tablet for anti-inflammatory and immunosuppressive therapy.
  • FERRITIN-TR CAPSULE Ferrous Sulphate and Folic Acid combination capsule for iron deficiency anemia treatment and supplementation.
  • AMBKUST Montelukast 10mg leukotriene receptor antagonist tablet for asthma and allergic airway disease management.
  • MYZID 500 TABLET Azithromycin Dihydrate 500mg macrolide antibiotic tablet for bacterial infection treatment.
  • MYCIN SUSPENSION Erythromycin Ethyl Succinate macrolide antibiotic oral suspension for bacterial infection treatment.
  • HITFLAM (Diclofenac) Diclofenac Sodium NSAID available as 10gm topical gel, 75mg injection, and 100mg sustained-release tablet for pain and inflammation relief.
  • NAPROXIN TABLET Naproxen 500mg NSAID tablet for pain, inflammation, and fever management.
  • ADOREX (Domperidone) Domperidone prokinetic available as 5mg/ml pediatric drops, 5mg/5ml oral suspension, and 10mg tablets for gastrointestinal motility disorders.
  • OM (Omeprazole 20mg and 40mg) Omeprazole BP proton pump inhibitor capsules in 20mg (100s pack) and 40mg (30s pack) strengths for gastric acid-related disorders.
  • VITEX INJECTION Vitamin B-Complex injection for parenteral vitamin supplementation.
  • SERA TABLET Sertraline HCL 50mg SSRI tablet for depression and related psychiatric conditions.
  • NOSTIS TABLET Glucosamine Sulphate and Chondroitin Sulphate tablet for cartilage formation support in joint health.
  • DOXILIN CAPSULE Doxycycline 100mg tetracycline antibiotic capsule for bacterial infection treatment.
  • FOLAC TABLET Folic Acid 5mg tablet for vitamin supplementation and prenatal care.
  • AMBEECAL (Calcium Carbonate) Calcium Carbonate 500mg tablet (AMBEECAL) and Calcium Carbonate plus Vitamin D3 tablet (AMBEECAL-D) for calcium supplementation and bone health.

Quantifiable outcome

  • Established in 1976, with first year sales over 1 Crore BDT
  • +1 more outcomes

Companies that use Ambee

Customer profile

Segments2 records

Ideal customer profiles2 records

Ambee technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Ambee partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Medimpex HungarycoreStrategic or Co-development Partner · 1 January 1976Ambee entered into a joint venture with Medimpex of Budapest, Hungary (a famous multinational company). The venture began operations with a modest portfolio of 17 jointly developed products and is now operating at full scale with an expanded range of 76 products. This partnership brings global pharmaceutical expertise to Bangladesh manufacturing operations.

Scale indicators8 records

Recent moves7 records

Expansion highlights4 records

Ambee competitors and assessment

Company assessment

Direct peers

  • Renata PLC: Leading Bangladeshi pharma manufacturer (formerly Pfizer Bangladesh) producing generics, animal health, and specialty products. Direct competitor with broader therapeutic coverage than Ambee.
  • Aristopharma Limited: Bangladesh-based generic pharmaceutical manufacturer with a broad portfolio of tablets, capsules, liquids, and injectables. Direct competitor in the domestic Bangladesh generics market.
  • Drug International Limited: Bangladeshi generic pharmaceutical manufacturer producing tablets, capsules, liquids, and injectables. Closely comparable to Ambee in product categories and Bangladesh market focus.
  • Square Pharmaceuticals: Largest pharmaceutical manufacturer in Bangladesh, producing generics across tablets, capsules, liquids, and injectables. Direct competitor to Ambee in domestic Bangladesh generics, also exporting regionally.
  • ACI Limited (Pharma Division): Diversified Bangladeshi conglomerate with a significant pharmaceutical division manufacturing generics across multiple therapeutic areas. Competes directly with Ambee in domestic Bangladesh market.
  • Healthcare Pharmaceuticals: Bangladesh-based pharmaceutical manufacturer with broad generic portfolio and own nationwide distribution. Comparable mid-sized competitor to Ambee in domestic market.
  • Eskayef Pharmaceuticals: Bangladesh-based pharmaceutical manufacturer producing generics in tablets, capsules, liquids, injectables and creams. Directly comparable to Ambee in size, product mix, and distribution model.
  • Incepta Pharmaceuticals: One of the top Bangladeshi pharmaceutical companies producing a wide range of generics including tablets, capsules, injectables, and biologics. Comparable in product breadth and domestic distribution model to Ambee.
  • Beximco Pharmaceuticals: Major Bangladeshi generic pharma manufacturer with broad therapeutic portfolio and export operations. Competes directly with Ambee across multiple therapeutic categories in Bangladesh and export markets.
  • Globe Pharmaceuticals: Bangladeshi generic pharma manufacturer producing a wide range of therapeutic categories. Closely comparable to Ambee in scale, product portfolio, and Bangladesh domestic market focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Ambee social profiles

Digital presence

Ambee compliance and trust

Trust signal

Compliance2 records

Ambee financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ambee leadership team

Management profile

Number of profiles

Profiles10 records

Ambee funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ambee M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ambee

What does Ambee do?

Ambee Pharmaceuticals PLC manufactures and sells over 120 generic pharmaceutical formulations including tablets, capsules, liquids, gels, and injectables across multiple therapeutic categories. Products are manufactured at WHO cGMP compliant facilities in Dhaka, Bangladesh, with 76 formulations developed through a joint venture with Medimpex Hungary. The company distributes products nationwide in Bangladesh through its own sales depots and field force, and exports to Afghanistan, Myanmar, Cambodia, and Bhutan via international distribution partners.

Is Ambee a public or private company?

Ambee is a public company. It is classified as public and is currently operating.

When was Ambee founded?

Ambee was founded in 1976. It employs 51 to 100 people.

Where is Ambee based?

Ambee is headquartered in Dhaka, Bangladesh, in the Asia region.

How does Ambee make money?

Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are joint Venture Products.

Who are Ambee's main competitors?

Direct peers on record are Renata PLC, Aristopharma Limited, Drug International Limited, Square Pharmaceuticals, ACI Limited (Pharma Division), Healthcare Pharmaceuticals, Eskayef Pharmaceuticals, Incepta Pharmaceuticals, Beximco Pharmaceuticals and Globe Pharmaceuticals.

Does Ambee have an API?

No public API is recorded for Ambee.

What industry is Ambee in?

Ambee's product category is Generic Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals